Results 91 to 100 of about 1,213 (179)

ABO and Rh Hemolytic Disease of the Fetus and Newborn

open access: yesWSEAS Transactions on Biology and Biomedicine
Hemolytic disease of the fetus and newborn (HDFN) is a blood disorder in which red blood cells are destroyed faster, leading to anemia. Our study focused on immune-mediated HDFN. The study included 86 newborns with HDFN. Samples were provided to two clinics in Georgia. Coombs tests were performed to confirm the presence of HDFN.
Shorena Gabaidze   +6 more
openaire   +1 more source

Pyroptosis in Preeclampsia: Placenta‐to‐Maternal Organ Communication, Molecular Mechanisms, and Therapeutic Targets

open access: yesComprehensive Physiology, Volume 16, Issue 6, December 2026.
Schematic diagram illustrating the potential mechanisms and core molecules contributing to the development of PE via mediating pyroptosis: focus on trophoblasts and endothelial cells. Pyroptosis of trophoblast cells in the placenta of preeclampsia not only inhibits its invasion, migration, and differentiation, causing local infiltration and ...
Xianyi Zhou   +5 more
wiley   +1 more source

Severe cholestasis in neonates with hemolytic disease of the fetus and newborn - a case report

open access: yes
Hemolytic disease of the fetus and newborn (HDFN) may cause severe cholestasis with direct bilirubin concentrations reaching up to 50 times the upper limit of normal.
Natalia Mazanowska   +9 more
core   +1 more source

Hemolytic Disease of the Fetus and Newborn due to an Anti-LU1 (anti-Lu<sup>a</sup>) Alloantibody: A Case Report

open access: yesTransfusion Medicine and Hemotherapy
Introduction: Many erythrocyte antibodies have been reported to cause hemolytic disease of the fetus and newborn (HDFN), but Lutheran (LU) alloantibodies are normally not involved in HDFN.
Elke Weinig   +4 more
doaj   +1 more source

Comparing functionality, anxiety and depression during pregnancy and postpartum in women with hypertensive disorders: Findings from the WOICE assessment

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 3, Page 1598-1607, December 2026.
Abstract Objective To describe the use of the WOICE tool for assessing non‐severe maternal morbidities among pregnant and postpartum women with hypertensive disorders. Methods Secondary analysis of a previously published cross‐sectional study performed in Brazil, with the inclusion of women with hypertensive disorders (pre‐eclampsia, chronic ...
Stephanie Pabón Lozano   +6 more
wiley   +1 more source

Maternal IgG in hemolytic disease of the fetus and newborn-ABO incompatibility

open access: yes
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a type of anemia in the fetus or newborn, characterized by anemia, jaundice, hyperbilirubinemia, and brain damage. IgG is the only antibody that can cross the placenta. The IgG subtypes have
Wibowo, Heri   +2 more
core   +1 more source

Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 4, December 2026.
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang   +16 more
wiley   +1 more source

Unraveling complexity: A case report on ABO hemolytic disease of the fetus newborn in a preterm neonate and delayed hemolytic transfusion reaction in the beta thalassemic mother due to alloanti kidd a antibody

open access: yesAsian Journal of Transfusion Science
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana   +5 more
doaj   +1 more source

Thrombocytopenia in Pregnancy: A 5‐Year Analysis of Characteristics and Practices From a Tertiary Academic Center

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 6, Page 1320-1329, December 2026.
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley   +1 more source

Noninvasive approach for the management of hemolytic disease of the fetus

open access: yes, 2009
Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies directed against paternally inherited antigens on fetal red cells, and it is still a problem in affected pregnancies despite the routine use of anti-D immunoglobulin ...
Soothill, PW   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy